Ideaya Biosciences Inc (IDYA) Dividend History

$25.83 $-1.15

Dividend Score
Dividend Yield

Annual Payment

Payout Ratio
Dividend Increases
0 yrs

Price Chart

Key Metrics

Sector Healthcare
Industry Biotechnology
Avg daily volume 534,596
Market cap 1,552,950,000
Beta 0.8
Trailing 12 Month EPS -1.51
Next Earnings Date
Ex-dividend date
P/E ratio -20.94

Company Description

ideaya biosciences is an oncology-focused biotechnology company committed to the discovery of personalized synthetic lethality medicines targeting dna damage and repair for genetically defined patient populations and immuno-oncology therapies targeting the tumor microenvironment. founded in 2015, ideaya’s investors include 5am ventures (5am), canaan partners (canaan), celgene, wuxi healthcare ventures (wuxi), novartis institute of biomedical research, and alexandria real estate. the company has assembled a world-class drug discovery team and scientific advisory board (sab) that is represented by a nobel laureate and three members of the national academy of sciences. ideaya is located in south san francisco and la jolla, california.

Dividend Payments

Forward Yield
Forward Payment

Trailing Yield
Trailing Payment

Last Increase
> 10 Years Ago
Last Cut
> 10 Years Ago

5 Year Average Yield
Vs Current Yield

5 Year Div Growth Rate
Payment Frequency

Historical Dividend Payments